FDA Inspection
B Braun Melsungen Ag- AktiengesellschaftB Braun Melsungen Ag- Aktiengesellschaft – FDA Inspection, Aug 29, 2017
Record Details
This FDA Inspection record concerns B Braun Melsungen Ag- Aktiengesellschaft, with an inspection on August 29, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Christophe T. Peters (Issuing Officer)
- Kellia N. Hicks (FDA Associated Person)
View Company Profile
ID · edce242f-9d32-44a8-9913-4724ff5a2625
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1025753
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of B Braun Melsungen Ag- Aktiengesellschaft
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 13, 2024 | Not classified | Office of Inspections and Investigations | |
| January 22, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for B Braun Melsungen Ag- Aktiengesellschaft
- FDA Inspection 1263340 - 2024-11-13
- FDA Inspection 1081920 - 2019-01-22
- FDA Inspection 884341 - 2014-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.